CTA is Not Useful for Diagnosing Reactive Gliosis
CTA (computed tomography angiography) would not help with diagnosing reactive gliosis, as this imaging modality is designed to visualize blood vessels, not cellular pathology within brain tissue.
Why CTA is the Wrong Test
CTA is specifically designed to evaluate vascular structures including:
- Aneurysms
- Arteriovenous malformations
- Vascular stenosis or occlusion
- Arterial dissections
- Vascular malformations 1
Reactive gliosis is a cellular response involving astrocyte and microglial cell hypertrophy and/or proliferation—it is not a vascular abnormality. 2 This pathologic process occurs at the microscopic cellular level and cannot be visualized by vascular imaging techniques.
What Reactive Gliosis Actually Is
Reactive gliosis represents a nonneoplastic reaction of glial cells that occurs in response to:
- Neuronal degeneration or necrosis
- Inflammation with parenchymal damage
- Microenvironmental alterations in neural tissue
- Various CNS injuries 2
This is fundamentally a histopathologic diagnosis requiring tissue-level visualization, not vascular imaging.
Appropriate Imaging for Suspected Gliosis
If you suspect reactive gliosis based on clinical presentation, the appropriate imaging would be:
MRI of the brain (with and without contrast if needed) to:
- Identify areas of parenchymal signal abnormality
- Detect associated structural lesions
- Evaluate for inflammation, edema, or mass effect
- Guide potential biopsy if needed
Definitive diagnosis requires:
- Brain biopsy with histopathologic examination
- Immunohistochemical staining (GFAP for astrocytes, Iba1 for microglia)
Common Pitfall
Do not order CTA when evaluating for parenchymal brain pathology like gliosis. CTA is reserved for suspected vascular pathology such as hemorrhage workup, stroke evaluation, or suspected vascular malformations 1. Ordering CTA for gliosis wastes resources, exposes patients to unnecessary radiation and contrast, and will not provide diagnostic information.